Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease

Abstract

Objective:

Epicardial and abdominal adipose tissues have recently been demonstrated to play inflammatory roles in coronary atherosclerosis. We sought to compare tissue adipocytokine levels of these two anatomically distinct adipose stores in patients with and without coronary artery diseases (CAD).

Design:

Samples of abdominal and epicardial fat tissues were harvested to detect the levels of adipocytokines and proinflammatory mediators.

Subjects:

Forty-six patients with CAD who underwent coronary artery bypass surgery and 12 non-CAD control subjects who underwent other types of open-heart surgery.

Measurements:

Tissue levels of adipocytokines (adiponectin, leptin and visfatin) and proinflammatory mediators (tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)) were determined by enzyme-linked immunosorbent assay.

Results:

Tissue levels of TNF-α, IL-6, leptin and visfatin were significantly higher in CAD patients relative to control subjects. In addition, significantly higher tissue levels of these four cytokines from abdominal fat depots were found compared to those from epicardial fat in CAD patients. Conversely, in comparison with control subjects, tissue levels of adiponectin were significantly reduced in CAD patients with a significantly lower tissue levels of abdominal than epicardial fat depots demonstrated.

Conclusion:

Abdominal adiposity may play more significant role than epicardial fat in the pathogenesis of coronary atherosclerosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Carr MC, Brunzell JD . Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004; 89: 2601–2607.

    Article  CAS  PubMed  Google Scholar 

  2. Lebovitz HE . The relationship of obesity to the metabolic syndrome. Int J Clin Pract 2003; Suppl(134): 18–27.

  3. Kershaw EE, Flier J . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548–2556.

    Article  CAS  PubMed  Google Scholar 

  4. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S . Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031–H2041.

    Article  CAS  PubMed  Google Scholar 

  5. Rajala MW, Scherer P . Minireview: The adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765–3773.

    Article  CAS  PubMed  Google Scholar 

  6. Wajchenberg BL . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697–738.

    Article  CAS  PubMed  Google Scholar 

  7. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW . Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273–2282.

    Article  CAS  PubMed  Google Scholar 

  8. Fisher FM, McTernan PG, Valsamakis G, Chetty R, Harte AL, Anwar AJ et al. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res 2002; 34: 650–654.

    Article  CAS  PubMed  Google Scholar 

  9. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–2466.

    Article  PubMed  Google Scholar 

  10. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251–255.

    CAS  PubMed  Google Scholar 

  12. Iacobellis G, Corradi D, Sharma AM . Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536–543.

    Article  PubMed  Google Scholar 

  13. Iacobellis G, Ribaudo M, Assael F, Vecci E, Tiberti C, Zappaterreno A et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88: 5163–5168.

    Article  CAS  PubMed  Google Scholar 

  14. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304–310.

    Article  PubMed  Google Scholar 

  15. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744–747.

    Article  CAS  PubMed  Google Scholar 

  16. Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK . Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 2004; 89: 5577–5582.

    Article  CAS  PubMed  Google Scholar 

  17. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296–1301.

    Article  CAS  PubMed  Google Scholar 

  18. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476.

    Article  CAS  PubMed  Google Scholar 

  19. Pilz S, Maerz W, Weihrauch G, Sargsyan K, Almer G, Nauck M et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafjen RIsk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2006; 364: 251–255.

    Article  CAS  PubMed  Google Scholar 

  20. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737.

    Article  CAS  PubMed  Google Scholar 

  21. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426–430.

    Article  CAS  PubMed  Google Scholar 

  22. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71: 536–539.

    Article  PubMed  Google Scholar 

  23. Sacks HS, Fain JN . Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907–917.

    Article  CAS  PubMed  Google Scholar 

  24. Rabkin SW . Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007; 8: 253–261.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Li-Fong Jo, Hwei-Fong Chen and Shou-Yun Lu for their technical assistance and data collection, and Yi-Hsien Yang for the statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W-T Lai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, KH., Chu, CS., Lee, KT. et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes 32, 268–274 (2008). https://doi.org/10.1038/sj.ijo.0803726

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803726

Keywords

This article is cited by

Search

Quick links